Session Details

[29-60-am]Biophysics 4

Sun. Mar 29, 2026 9:30 AM - 11:30 AM JST
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Room 60 (4101, Bldg. 4, Area 4 [1F]) (1)
Discusser: Hanako Ishida, Toshihiko Sugiki

[29-60-am-01]Interaction Analysis between PBP2a from MRSA and β-Lactam Antibiotics

○Asuka Shibuya1, Takumi Iketani1, Masatoshi Yoshikubo1, Akio Kitamura1, Sadahiro Kamiya1, Yoshikazu Nishiguchi1, Michiyoshi Nukaga1 (1. Fac. Pharm. Sci., Josai Int. Univ.)

[29-60-am-02S]Evaluation of Protease Inhibitors Using the BioLayer Interference (BLI) Method: Validation with HRV3C Protease and Application to Coronavirus 3CL Protease

○Sayaka Nagai1, Mizuki Abe1, Takashi Saitoh1 (1. Faculty of Pharmaceutical Sciences Hokkaido University of Science)

[29-60-am-03S]Structural Analysis of Class A Carbapenemase PenA E166 Variants from Burkholderia multivorans

○Takumi Iketani1, Tyuji Hoshino2, Maria F. Mojica3, Michiyoshi Nukaga 1 (1. Grad. Sch. Pharm. Sci., Josai International Univ., 2. Grad. Sch. Pharm. Sci., Chiba Univ., 3. Dept. MOl. Biol. Microbiol., CWRU Sch. Med.)

[29-60-am-04S]Evaluation of the induced fit model based on amino acid residue fluctuations in the T4 lysozyme L99A mutant

○Mori Tomohiro1, Fukushima Satoshi 1, Ogata Koji 1 (1. Sanyo-Onoda City University)

[29-60-am-05S]Structural studies of Spen family proteins involved in dosage compensation

○Hiroki Oikawa1, Tomoki Sakamoto1, Karin Nomura1, Mitsuhiro Takeda1, Hiroshi Aoyama1, Masaki Mishima1 (1. Dep. Pharm., Tokyo Univ. of Pharm. and Life Sci.)

[29-60-am-06]Structural analysis of a human oxidized nucleotide hydrolase by neutron and time-resolved X-ray crystallography

Keisuke Hirata1, Kana Fujimiya2, Andreas Ostermann3, Tobias E Schrader4, Takeshi Hiromoto5, Masataka Goto1, Takao Arimori6, Yu Hirano5,7, Katsuhiro Kusaka8, Taro Tamada5,7,8, ○Teruya Nakamura1 (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Sch. Pharm., Kumamoto Univ., 3. Technische Universität München, 4. Jülich Centre for Neutron Science, 5. QST, 6. Institute for Protein Research, The University of Osaka, 7. cQUEST, 8. CROSS)

[29-60-am-07]Structural analysis of CspD protein regulating transcriptional termination.

○Yuta Mizuno1, Tomoki Sakamoto1, Hikaru Imai1, Mituhiro Takeda1, Hiroshi Aoyama1, Teppei Morita2, Masaki Mishima1 (1. Tokyo University of Pharmacy and Life Science, 2. Kyorin University)

[29-60-am-08]Site-specific D-isomerization of Asp residues enhances the seeding effect of amyloid-β

○Takuya Murata1, Naoko Utsunomiya-Tate1 (1. Fac. Pharm. Sci., Teikyo Univ.)

[29-60-am-09S]Copper-dependent monoamine oxidation and oxidative stress induced by amyloid-β fibrillization

○Takumi Kurihara1, Saki Kuroda2, Minami Kanaeko2, Takashi Miura1,2 (1. Grad.Sch.Pharm.Sci.,Int.Univ.Health and Welfare, 2. Dept.Pharm.Sci.,Int.Univ.Health and Welfare)

[29-60-am-10S]Methionine-type ATCUN copper-binding motif that suppresses oxidative dopamine conversion

○Koto Hagiwara1, Runa Uchiyama1, Nanaka Takahashi1, Risa Shimizu1, Takashi Miura1 (1. Dept. Pharm. Sci., Int. Univ. Health and Welfare)

[29-60-am-11S]Synthesis and Evaluation of IR820-Modified Alkoxyamine Derivative for Near-Infrared Light-Activated Carbon Radical Generator

○Karin Nagahama1, Toshihide Yamasaki1, Kohei Sano1, Takahiro Mukai1 (1. Kobe Pharm. Univ.)